Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

199
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
199
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

92
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
92
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

160
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
160
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

36
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
36
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

153
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
153
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

136
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
136

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons.

Nature reviews. Clinical oncology·2026
Same author

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

The Lancet. Oncology·2026
Same author

Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Population screening for Helicobacter pylori to reduce gastric cancer - Authors' reply.

Lancet (London, England)·2025
Same author

Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/- Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability-High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

関連する実験動画

Updated: May 9, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

589

胃がん

Raghav Sundar1, Izuma Nakayama2, Sheraz R Markar3

  • 1Department of Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore.

Lancet (London, England)
|May 4, 2025
PubMed
まとめ
この要約は機械生成です。

胃がんは世界的な健康問題で 早期発症が増加しています 手術,免疫療法,精密医療などの治療の進歩は 患者の生存率と生活の質を改善することを目的としています.

さらに関連する動画

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

940
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

10.7K

関連する実験動画

Last Updated: May 9, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

589
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

940
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

10.7K

科学分野:

  • 腫瘍学
  • 胃腸内科
  • 公衆衛生

背景:

  • 胃がんは,高い死亡率と顕著な地理的発生率の変動により,世界的な健康負担を伴う.
  • この病気は50歳未満の個人にますます影響し,早期発症の懸念傾向を強調しています.
  • 既知の危険因子には,ヘリコバクター・パイロリ感染症,ライフスタイル選択 (食事,肥満,喫煙),遺伝的易感性などがあります.

研究 の 目的:

  • 胃がん管理の現状を総合的に説明する.
  • 治療方法や新たな治療戦略の最近の進歩を強調する.
  • 精密医療と早期発見を通じて 胃がんの治療結果を改善するための将来の方向性を概説する.

主な方法:

  • 胃がんの発生率と死亡率に関する現在の疫学データのレビュー
  • 局所的に進行したおよび進行した胃がんの標準および新興治療プロトコルの分析.
  • 免疫療法や標的治療を含む新しい診断と治療アプローチの探索

主要な成果:

  • 胃がんの発生率は地域によって異なるが,早期発症の症例は増加している.
  • 標準的な治療には,手術 (D2リンパ切除術),化学療法,放射線療法が含まれています.
  • 最低侵襲手術,免疫チェックポイント阻害剤,標的治療は,手術可能なおよび進行した病気のためにますます採用されています.

結論:

  • 早期発見と総合的な診断は 治療の最適化に不可欠です
  • 標的治療や 次世代の免疫療法などの 新興治療法により 生存率が向上する見込みがあります
  • 将来の管理戦略は,総合的な効果と予後を改善するために,精密医療,免疫療法,早期発見,および多学科ケアを強調しています.